Peptide Receptor Radionuclide Therapy or Everolimus in Metastatic Neuroendocrine Tumors: The SeqEveRIV Study, a National Study from the French Group of Endocrine Tumors and Endocan–RENATEN Network
Saved in:
Published in | Journal of Nuclear Medicine Vol. 65; no. 9; pp. 1416 - 1422 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
01.09.2024
|
Online Access | Get full text |
Cover
Loading…
ISSN: | 0161-5505 2159-662X |
---|---|
DOI: | 10.2967/jnumed.123.267363 |